After the Product-Centric Medical Industry – What’s Next?
For decades, the medical device industry has reaped rewards by providing new technologies and solutions that improve healthcare delivery. Now, more than 8000 new medical devices enter the U.S. market each year1Â as the industry faces sweeping changes that will not only impact the life cycle of many existing products, but also future innovations. New payment models, patients replacing physicians as stewards of their care, a changing regulatory framework, and data as a central solution to implement these strategies are all converging trends requiring medical device makers to prepare their organizations to adapt to...
Source: MDDI - January 25, 2019 Category: Medical Devices Authors: David Hahn Tags: Digital Health Source Type: news
Bittersweet Ending to Asbestos Cleanup in Libby, Montana
The asbestos cleanup of Libby, Montana, is coming to a celebrated close.
The U.S. Environmental Protection Agency will soon end the largest, longest-running asbestos cleanup project in American history.
It’s a bittersweet ending to what is left behind.
The 19-year, $600 million EPA Superfund project aimed to right the wrongs created by the shuttered W.R. Grace and Co. vermiculite mine.
Once the lifeblood of the community, it also became a cold-hearted killer.
Although the mine was closed almost 30 years ago, health officials have since documented more than 400 deaths linked to asbestos-related diseases such as mes...
Source: Asbestos and Mesothelioma News - December 11, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news
Does She Have SCID?
Discussion
Severe-combined immunodefiency (SCID) is actually a group of inherited disorders with an absence or dysfunction of T, B and NK cells that results in severe dysfunction of the immune system. SCID is a primary immunodeficiency. SCID was thought to be a rare disorder but with the advent of neonatal screening the incidence in the US general population is estimated at ~1 in 58,000 live births, but with numbers higher or lower depending on the specific population.
Patients often have failure to thrive, oral candidiasis, and diarrhea as infants as well as a variety of infectious diseases. They can also have interstit...
Source: PediatricEducation.org - December 3, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Paradoxical Development of Panuveitis and Granulomatous Interstitial Lung Disease Associated with Adalimumab Therapy for Psoriasis
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - November 19, 2018 Category: Respiratory Medicine Authors: GAtherton Source Type: news
CU researchers find common genetic link in lung ailments
(University of Colorado Anschutz Medical Campus) An international research team led by members of the University of Colorado School of Medicine faculty has identified a genetic connection between rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis. The findings are published in the current issue of the New England Journal of Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 22, 2018 Category: International Medicine & Public Health Source Type: news
Medical News Today: How can psoriasis affect the lungs?
Psoriasis causes widespread inflammation that can affect the skin and several organ systems. A person with psoriasis may experience lung-related complications, including lung fibrosis and interstitial lung disease. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 1, 2018 Category: Consumer Health News Tags: Psoriasis Source Type: news
Low Vitamin D Levels Tied to Interstitial Lung Disease
Findings include both high - attenuation areas, interstitial lung abnormalities on scans (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 21, 2018 Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Pulmonology, Journal, Source Type: news
Low Vitamin D Levels Tied to Interstitial Lung Disease
FRIDAY, Sept. 21, 2018 -- Vitamin D deficiency is independently associated with subclinical interstitial lung disease (ILD) and its progression, according to a study recently published in the Journal of Nutrition.
Samuel M. Kim, M.D., from the Johns... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 21, 2018 Category: Pharmaceuticals Source Type: news
Medical News Today: What to know about rheumatoid lung disease
Rheumatoid lung disease happens when rheumatoid arthritis (RA) affects a person's lungs. Lung issues arise in around 10 percent of people with RA, including interstitial lung disease or lung nodules. In this article, we give an overview of rheumatoid lung disease, including symptoms, treatments, and life expectancy. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 28, 2018 Category: Consumer Health News Tags: Rheumatoid Arthritis Source Type: news
Researchers Find Link Between Vitamin D and Asbestosis
This study was not designed to explain whether supplementing with vitamin D will protect against asbestosis. This new research also does not examine if taking vitamin D will slow down the progression of existing ILD.
Still, there are a lot of good reasons to pay attention to the sunshine vitamin. Regardless of whether a person has been exposed to asbestos, no one should ignore very low vitamin D levels.
People already diagnosed with an asbestos-related cancer, may benefit from a quick check of vitamin D levels.
According to the medical literature, up to 80 percent of people with cancer may be vitamin D deficient.
People ca...
Source: Asbestos and Mesothelioma News - July 16, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news
Vitamin D Deficiency Could Be Lung Disease Risk
MONDAY, June 25, 2018 -- Low levels of vitamin D are associated with an increased risk of a disease that causes lung inflammation and scarring, researchers say.
About 200,000 cases of interstitial lung disease (ILD) are diagnosed each year in the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 25, 2018 Category: General Medicine Source Type: news
Low vitamin D linked to scarring lung disease
Lower than normal levels of vitamin D in the blood were linked to increased risk of early interstitial lung disease, according to an analysis of a new study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 19, 2018 Category: Consumer Health News Source Type: news
Low vitamin D levels associated with scarring lung disease
(Johns Hopkins Medicine) Reviewing medical information gathered on more than 6,000 adults over a 10-year period, Johns Hopkins researchers have found that lower than normal blood levels of vitamin D were linked to increased risk of early signs of interstitial lung disease (ILD). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 19, 2018 Category: International Medicine & Public Health Source Type: news
Barriers to Timely Diagnosis of Interstitial Lung Disease Barriers to Timely Diagnosis of Interstitial Lung Disease
What are the barriers patients with interstitial lung diseases may face in obtaining a timely and accurate diagnosis?BMC Pulmonary Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 11, 2018 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news
FDA grants Fast Track designation to nintedanib for the treatment of systemic sclerosis with associated interstitial lung disease
Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to nintedanib for the treatment of systemic sclerosis with associated interstitial lung disease (SSc-ILD). The FDA's Fast Track designation facilitates the development of new therapies that treat serious conditions and fulfill an unmet medical need in an effort to get treatments to those in need sooner. (Source: World Pharma News)
Source: World Pharma News - March 19, 2018 Category: Pharmaceuticals Tags: Featured Boehringer Ingelheim Business and Industry Source Type: news
